factor

(redirected from granulocyte-macrophage colony-stimulating factor)
Also found in: Dictionary, Thesaurus, Medical, Legal, Encyclopedia, Wikipedia.
Related to granulocyte-macrophage colony-stimulating factor: GM-CSF

Factor

A financial institution that buys a firm's accounts receivable and collects the accounts.

Factor

A third party that buys a firm's accounts receivable. If a firm is not confident in its ability to collect on its credit sales, it may sell the right to receive payment to the factor at a discount. The factor then assumes the credit risk associated with the accounts receivable. This provides the firm immediate access to working capital, which is important, especially if the firm has a cash flow problem. The price of factoring is determined by the creditworthiness of the firm's customer, not of the firm itself. It is also known as accounts receivable financing.

factor

A firm that purchases accounts receivable from another firm at a discount. The purchasing firm then attempts to collect the receivables.

factor

To sell accounts receivable to another party at a discount from face value. Thus, a firm in need of cash to pay down short-term debt may decide to factor its accounts receivable to another firm.

factor

  1. a firm that purchases TRADE DEBTS from client firms. See FACTORING.
  2. a firm that buys in bulk and performs a WHOLESALING function.
  3. an input (for example raw material, labour, capital) which is used to produce a good or provide a service.

factor

  1. 1a FACTOR INPUT that is used in production (see NATURAL RESOURCES, LABOUR, CAPITAL).
  2. a business that buys in bulk and performs a WHOLESALING function.
  3. a business that buys trade debts from client firms (at some agreed price below the nominal value of the debts) and then arranges to recover them for itself. See FACTOR MARKET, FACTORING.
References in periodicals archive ?
0001 * * Significant Table 2 | Granulocyte-macrophage colony-stimulating factor serum level by patient variables.
Production of granulocyte-macrophage colony-stimulating factor in a patient with metastatic chest wall large cell carcinoma.
Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis.
More recent studies have focused on the presence and function of granulocyte-macrophage colony-stimulating factor (GMCSF) in the pulmonary alveoli.
It has been genetically modified to attenuate its virulence and engineered to express granulocyte-macrophage colony-stimulating factor (GM-CSF), while remaining susceptible to antiviral treatments such as acyclovir.
Treatment with sargramostim, a yeast-derived, recombinant human granulocyte-macrophage colony-stimulating factor, is a striking departure from therapy with the immunosuppressive agents usually used to treat Crohn's disease.
Production of granulocyte-macrophage colony-stimulating factor by cultured human tracheal epithelial cells.
The 14 women whose tumors ex pressed the E75 peptide on surfaces of the HER2/neu protein were given a vaccine aimed at that specific target antigen plus granulocyte-macrophage colony-stimulating factor (GM-CSF) intended to trigger a generalized immune response.
The 14 women whose tumors expressed the E75 peptide on surfaces of the HER2/neu protein were given a vaccine aimed at that specific target antigen plus granulocyte-macrophage colony-stimulating factor (GM-CSF) intended to trigger a generalized immune response.
Absence of breast cancer cells in a single-day peripheral blood progenitor cell collection after priming with cyclophosphamide and granulocyte-macrophage colony-stimulating factor.

Full browser ?